YCQH Agricultural Tech (OTC:YCQH) Stock, Quote.Headers.trade-ideas

YCQH Agricultural Technology Co Ltd operates in a bio-carbon-based fertilizer trading business, including wholesaling and retailing to customers mainly based in the People's Republic of China, sourcing directly from producers in China. The company has three reportable segments namely bio-carbon-based fertilizer trading business, online retailing business and beauty products trading business.

YCQH AGRIC TECHNOLOGY CO by YCQH AGRIC TECHNOLOGY CO LTD.

YCQH Agricultural Technology Co Ltd

U.S. stocks traded higher this morning, with the Nasdaq Composite surging more than 400 points on Thursday.
Following the market opening Thursday, the Dow traded up 1.44% to 42,100.00 while the NASDAQ rose 2.30% to 17,976.85. The S&amp;P 500 also rose, gaining, 1.65% to 5,710.85.
Check This Out: <a href="https://www.benzinga.com/news/24/09/40937584/alphabet-mcdonalds-and-2-other-stocks-executives-are-selling">Alphabet, McDonald&#8217;s And 2 Other Stocks Executives Are Selling</a>
Leading and Lagging Sectors Information technology shares jumped by 2.7% on Thursday.
In trading on Thursday, utilities shares fell by 0.1%.
Top Headline
U.S. initial jobless claims fell by 12,000 from the prior week to 219,000 in the week ending September 14, compared to market expectations of 230,000.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Telesis Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBIO#NASDAQ">TBIO</a>) shares shot up 245% to $4.67. Telesis Bio recently announced that it has notified the Nasdaq Stock Market of its decision to delist.</li>
<li>Shares of Signing Day Sports, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SGN#NYSE">SGN</a>) got a boost, surging 185% to $0.3702 after the company announced it will acquire sports gaming technology company Swifty Global.</li>
<li>Zeo Energy Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZEO#NASDAQ">ZEO</a>) shares were also up, gaining 153% to $2.96 after declining around 9% on Wednesday.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Haoxi Health Technology Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HAO#NASDAQ">HAO</a>) shares dropped 74% to $0.77. Haoxi Health Technology announced the pricing of a $12 million underwritten follow-on public offering of 4 million units at a price of $3/unit.</li>
<li>Shares of Progyny, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PGNY#NASDAQ">PGNY</a>) were down 39% to $14.96 after a client elected to exercise an option to terminate its services agreement with the company.</li>
<li>Vivos Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VVOS#NASDAQ">VVOS</a>) was down, falling 23% to $3.19 after the company announced a $4.3 million registered offering of 1.36 million shares of common stock at $3.15 per share.</li>
</ul>
Commodities In commodity news, oil traded up 1.1% to $71.71 while gold traded up 0.2% at $2,602.70.
Silver traded up 2.2% to $31.355 on Thursday, while copper rose 1.7% to $4.3720.
Euro zone
European shares were higher today. The eurozone's STOXX 600 climbed 1.4%, Germany's DAX climbed 1.6% and France's CAC 40 jumped 2%. Spain's IBEX 35 Index rose 0.7%, while London's FTSE 100 rose 1%.
The Bank of England maintained the Bank Rate at 5% during its September meeting, after cutting rates by 25 bps in August. The current account surplus in the Eurozone increased to €48 billion in July from €25.5 billion in the year-ago period.
Asia Pacific Markets
Asian markets closed higher on Thursday, with Japan's Nikkei 225 gaining 2.13%, Hong Kong's Hang Seng Index surging 2%, China's Shanghai Composite Index gaining 0.69% and India's BSE Sensex gaining 0.29%.
Hong Kong's unemployment rate came in unchanged at 3% in the three months ending August. The Hong Kong Monetary Authority cut its base rate by 50bps to 5.25% at its recent meeting.
Economics
<ul>
<li>The U.S. reported a current account deficit of $266.8 billion in the second quarter versus a gap of $241 billion in the prior period and higher than market estimates of a $260 billion gap.</li>
<li>U.S. initial jobless claims fell by 12,000 from the prior week to 219,000 in the week ending September 14, compared to market expectations of 230,000.</li>
<li>The Philadelphia Fed Manufacturing Index climbed to 1.7 in September from -7 in the previous month and topping market estimates of -1.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40937617/top-3-defensive-stocks-you-may-want-to-dump-in-september">Top 3 Defensive Stocks You May Want To Dump In September</a></li>
</ul>

Equities

News

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

PGNY

TBIO

VVOS

Nasdaq Surges 400 Points; US Jobless Claims Fall To 219,000

Wells Fargo analyst Steven Cahall downgrades Boston Omaha (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOC#NYSE">BOC</a>) from Overweight to Equal-Weight and lowers the price target from $17 to $15.

Downgrades

Price Target

Analyst Ratings

Wells Fargo Downgrades Boston Omaha to Equal-Weight, Lowers Price Target to $15

Palantir Technologies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) shares are making new 52-week highs Thursday morning. Here&#8217;s a look at <a href="https://www.benzinga.com/markets/equities/24/09/40931562/cathie-woods-ark-invest-continues-dumping-robinhood-and-palantir-shares-as-interest-rates-fall">what&#8217;s going on</a>.
What Happened: Palantir shares are on watch Thursday after the company was awarded a new $99.8 million contract by the United States Army.
According to a <a href="https://www.defense.gov/News/Contracts/Contract/Article/3910169/">contract update</a> posted on the U.S. Department of Defense&#8217;s (DOD) website, Palantir has been awarded a $99.804 million firm-fixed-price contract that involves user licenses for the Maven Smart System AI tool, ancillary software support and hardware.
The DOD release states that the contract has an estimated completion date of Sept. 24, 2029.&nbsp;Work locations and funding will be determined with each order.
Palantir was previously awarded a <a href="https://www.benzinga.com/markets/equities/24/05/39079527/palantir-stock-shrugs-off-cramers-sell-call-as-480m-ai-contract-for-army-fuels-premarket-rally">$480 million firm-fixed-price contract</a> by the U.S. Army for the&nbsp;Maven Smart System&nbsp;prototype in May. That contract has an estimated completion date of May 28, 2029.
Palantir&#8217;s <a href="https://www.benzinga.com/news/earnings/24/08/40172453/palantir-q2-earnings-revenue-beat-eps-beat-customer-count-up-41-driven-by-strength-in-us-commercial#">latest quarterly results</a> showed that U.S. government revenue grew 24% year-over-year in the second quarter to $278 million. Total government revenue was up 23% year-over-year to $371 million.
Palantir is not due to report earnings again until sometime around the end of October. Analysts are currently forecasting earnings of 9 cents per share and revenue of $701.13 million, according to estimates from <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Palantir shares are also benefiting from strength across broader markets on the heels of a 0.5% rate cut from the Federal Reserve on Wednesday. This week&#8217;s 0.5% rate cut brought the&nbsp;target fed funds rate&nbsp;to a new range&nbsp;between 4.75% and 5%, down from a 23-year high of 5.25% to 5.5%. It was also the first rate cut since March 2020.
See Also: <a href="https://www.benzinga.com/markets/equities/24/09/40931562/cathie-woods-ark-invest-continues-dumping-robinhood-and-palantir-shares-as-interest-rates-fall#google_vignette">Cathie Wood&#8217;s Ark Invest Continues Dumping Robinhood And Palantir Shares As Interest Rates Fall</a>
PLTR Price Action: Palantir shares were down 0.4% at $36.24 at the time of publication, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: Shutterstock.

Contracts

Movers

PLTR

Palantir Stock Hits 52-Week Highs Thursday: What's Going On?

RBC Capital analyst Nik Modi reiterates General Mills (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GIS#NYSE">GIS</a>) with a Sector Perform and maintains $70 price target.

Reiteration

RBC Capital Reiterates Sector Perform on General Mills, Maintains $70 Price Target

WIIM

UROY

UUUU

Shares of uranium stocks are trading higher, possibly as the US investigates if China is helping Russia circumnavigate the commodity's ban. Also, Russian President Putin last week reportedly considered restrictions on uranium exports.

RBC Capital analyst Rishi Jaluria reiterates HubSpot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUBS#NYSE">HUBS</a>) with a Outperform and maintains $700 price target.

HUBS

RBC Capital Reiterates Outperform on HubSpot, Maintains $700 Price Target

<a href="https://www.defense.gov/News/Contracts/Contract/Article/3910169/" title="https://www.defense.gov/News/Contracts/Contract/Article/3910169/">https://www.defense.gov/News/Contracts/Contract/Article/3910169/</a>

GNTX

Reported September 18; Gentex Awarded $8.1M Contract Modification For HGU-56/P Aircrew Helmet System And Components, With Completion Expected By September 2025

Reported September 18; Teledyne FLIR Awarded $13.2M Contract Modification For IdentiFINDER Systems And Support, With Work To Be Completed By September 2027

FibroBiologics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FBLG#NASDAQ">FBLG</a>) ("FibroBiologics"), a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced that it has engaged with Southern Star Research to provide clinical research organization (CRO) services for FibroBiologics in Australia. Initial CRO services will include preparatory work for a Phase 1/2 clinical trial utilizing product candidate, CYWC628, to treat diabetic foot ulcers.

Biotech

Global

General

FBLG

FibroBiologics Engages Southern Star Research As Clinical Research Organization In Australia, Initial CRO Services Will Include Preparatory Work For A Phase 1/2 Clinical Trial Utilizing Product Candidate, CYWC628, To Treat Diabetic Foot Ulcers

Reported September 18; Northrop Grumman Awarded $17.9M Contract For Inertial Measuring Units For WSN-7 Weapon System, Work To Be Completed By June 2030

Reported September 18; Boeing Awarded $29.5M Contract For F/A-18 E/F Black III Windshield Panel Spares, Work To Be Completed By December 2029

Reported September 18; Raytheon Awarded $18.6M Contract For International Field Artillery Tactical Data Systems, With Completion Expected By September 2026, Funded By 2024 Foreign Military Sales To Georgia

Reported September 18; Palantir USG Awarded $99.8M Contract For Maven Smart System AI Tool, Software Support, And Hardware, With Completion Expected By September 2029

T-Mobile US, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMUS#NASDAQ">TMUS</a>) shares are trading higher today. The company disclosed long-term <a target="_blank" href="https://www.benzinga.com/pressreleases/24/09/b40925481/fueled-by-network-leadership-and-transformative-ai-enabled-customer-experiences-t-mobile-outlines-" rel="noreferrer noopener">goals, AI deals, and a dividend hike on Wednesday.</a>
T-Mobile revealed a three-year plan to drive growth. The strategy comprises expanding its AI-driven, digital-first approach, increasing market share in underpenetrated areas, boosting broadband growth, and exploring new revenue streams.
The company exceeded its 2021 Capital Markets Day goals, including building a solid network in America, expanding market reach, and achieving $8 billion in synergies from the Sprint merger.
Apart from this, T-Mobile plans to enhance its network leadership with advanced technologies like Massive MIMO, VoNR, and 5G Advanced, backed by its nationwide 5G standalone network.
In a separate release, T-Mobile and OpenAI disclosed a transformative multi-year partnership aimed at revolutionizing customer experience. This collaboration merges T-Mobile&#8217;s deep customer relationship skills with OpenAI&#8217;s cutting-edge <a target="_blank" href="https://www.benzinga.com/pressreleases/24/09/b40922898/t-mobile-and-openai-join-forces-to-revolutionize-the-customer-experience-with-first-ever-intent-dr" rel="noreferrer noopener">AI technology and R&amp;D capabilities</a>.
T-Mobile CEO Mike Sievert said, &#8220;T-Mobile is a company on the move with tremendous opportunities in front of us to further extend our outperformance in customer growth and translate that into strong top and bottom-line growth that will enable a compelling capital return opportunity over the next few years,&#8221;
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/equities/24/09/40925493/t-mobile-partners-with-nvidia-ericsson-and-nokia-to-pioneer-ai-driven-mobile-networks" rel="noreferrer noopener">T-Mobile Partners with NVIDIA, Ericsson, And Nokia to Pioneer AI-Driven Mobile Networks</a>
Outlook: T-Mobile expects service revenue between $75 billion and $76 billion and adjusted free cash flow of<a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener"> $18 billion-$19 billion in 2027</a>.
T-Mobile for Business (TFB) is anticipated to deliver double-digit growth, with overall service revenue projected to grow at a 5% CAGR from 2023 to 2027.
The company now targets 12 million 5G broadband customers by 2028, significantly raising its previous goal of 7 to 8 million by 2025.
The company projects core Adjusted EBITDA growth, targeting $38 billion&nbsp;to $39 billion in 2027, reflecting a 7% CAGR at the midpoint from 2023 and a $10 billion increase from 2023 at the high end of&nbsp;guidance.
This growth is expected to be fueled by operational leverage and efficiencies from technology, AI, and digital innovation.
Dividend Boost: T-Mobile disclosed that its Board of Directors has declared a cash dividend of $0.88 per share, reflecting a 35% increase from the previous quarter.
The dividend will be payable on December 12, 2024, to stockholders of <a target="_blank" href="https://www.benzinga.com/pressreleases/24/09/b40925518/t-mobile-announces-a-35-quarterly-dividend-increase" rel="noreferrer noopener">record as of November 27, 2024</a>.
Also, the company plans to allocate around $80 billion through 2027 for investments and shareholder returns, including up to $50 billion for dividends and share repurchases (in addition to the $25 billion already returned to shareholders).
Apart from this, T-Mobile introduced T-Priority, the world&#8217;s first 5G network slice dedicated to first responders, providing advanced connectivity solutions and <a target="_blank" href="https://www.benzinga.com/pressreleases/24/09/b40925495/t-mobile-introduces-t-priority-featuring-the-worlds-first-network-slice-for-first-responders" rel="noreferrer noopener">unparalleled support for emergency situations</a>.
Investors can focus on the stock via&nbsp;The Communication Services Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLC#NYSE">XLC</a>)and&nbsp;Invesco BuyBack Achievers ETF&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PKW#NASDAQ">PKW</a>).
Price Action: TMUS shares are up 1.04% at $198.73 at the last check Thursday.
Photo by viewimage on Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/09/40932937/apple-iphone-16-selling-at-a-greater-rate-than-last-year-says-t-mobile-ceo-amid-reports-of-lower" target="_blank" rel="noreferrer noopener">Apple iPhone 16 Selling At A &#8216;Greater Rate Than Last Year,&#8217; Says T-Mobile CEO Amid Reports Of Lower Demand: &#8216;People Are Buying Pros, They&#8217;re Buying Maxs… They&#8217;re Buying Up The Food Chain&#8217;</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Large Cap

Guidance

TMUS

T-Mobile Surpasses 2021 Capital Markets Day Goals, Sets New Ambitions, Boosts Dividend & More

Clinical Advisory Board to Provide Strategy for Advancing Preclinical Oncology Program in Mesothelioma
AUSTIN, Texas, Sept. 19, 2024 /PRNewswire/ -- <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4258494-1&amp;h=4023088732&amp;u=https%3A%2F%2Fwww.genprex.com%2F&amp;a=Genprex%2C+Inc.">Genprex, Inc.</a> ("Genprex" or the "Company") (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gnpx#NASDAQ">GNPX</a>), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced the formation of a Mesothelioma Clinical Advisory Board to support the Company's preclinical mesothelioma oncology program. The Board is comprised of four world-renown researchers from major research institutions specializing in the treatment of mesothelioma.

Penny Stocks

GNPX

Genprex Announces Formation Of Mesothelioma Clinical Advisory Board  To Provide Strategy For Advancing Preclinical Oncology Program In Mesothelioma

Wells Fargo analyst James Feldman upgrades Equity Lifestyle Props (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELS#NYSE">ELS</a>) from Equal-Weight to Overweight and raises the price target from $70.5 to $82.

Upgrades

Wells Fargo Upgrades Equity Lifestyle Props to Overweight, Raises Price Target to $82

Trump Media &amp; Technology Group Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>) shares are trading lower Thursday as lockup restrictions that have prevented certain insiders from selling shares <a href="https://www.benzinga.com/news/24/09/40869694/trump-media-faces-4b-downslide-as-shareholders-prepare-for-lockup-agreement-expiration">are set to expire</a>.
What To Know: Trump Media, the parent company of social media platform Truth Social,&nbsp;has been popular among retail investors since special purpose acquisition company Digital World first announced intentions to merge with the company. Trump Media made its public debut in late March. The stock traded as high as $79 before pulling back and trending lower.
Former President Donald Trump, who is the majority shareholder of Trump Media, as well as several other insiders, were restricted from selling any shares for approximately 180 days due to the lockup agreement. The lockup period expires Thursday, per <a href="https://www.cnbc.com/2024/09/18/djt-trump-media-slips-merger-lockup.html">CNBC</a>.
Trump Media shares have been very volatile since the start of the year. Just last week, the stock <a href="https://www.benzinga.com/general/social-media/24/09/40860859/trump-media-technology-shares-surge-former-president-says-hes-not-selling-or-leaving-truth-s">jumped as much as 25%</a> after Trump said he had &#8220;absolutely no intention of selling&#8221; any of his stake in the company. Trump reportedly owns close to a 57% stake in Trump Media. As of Wednesday&#8217;s close, the Republican presidential nominee&#8217;s&nbsp;stake was worth approximately $1.8 billion.
Trump Media shares fell 3.22% on Wednesday, a day ahead of the expiration. On Tuesday, shares slid more than 6% after a Delaware judge ruled that Trump Media breached a contract with ARC Global,&nbsp;ruling that the company must grant the early investor a larger portion of its stock than it planned to.
ARC Global reportedly holds a 4.77% stake in Trump Media. Those shares are likely going to be freed up for a potential sale once the lockup period expires on Thursday.
See Also: <a href="https://www.benzinga.com/news/24/09/40931458/obama-era-economist-says-she-is-pleasantly-surprised-that-jd-vance-thinks-the-economy-is-too-strong">Obama-Era Economist Says She Is &#8216;Pleasantly Surprised&#8217; That JD Vance Thinks The &#8216;Economy Is Too Strong For The Rate Cut&#8217;</a>
DJT Price Action: <a href="http://benzinga.com/quote/djt">Trump Media shares</a> were down 3.81% at $15.03 at the time of publication, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: Shutterstock.

Trump Media & Technology Group Stock Slides As Lockup Expiration Looms: What's Going On?

Haoxi Health Technology Limited (the "Company" or "HAO"), an online marketing solution provider headquartered in Beijing, China, today announced the pricing of its underwritten follow-on public offering (the "Offering") of 4,000,000 units (each a "Unit," and collectively, the "Units") at an offering price of $3.00 per Unit (the "Public Offering Price") for total gross proceeds of $12,000,000, before deducting underwriting discounts and other offering expenses. Each Unit consists of (i) one share of Class A Ordinary Share, par value $0.0001 per share (the "Class A Ordinary Share") (or one pre-funded warrant to purchase one Class A Ordinary Share (the "Pre-Funded Warrant")), (ii) one Series A warrant to purchase one Class A Ordinary Share (the "Series A Warrant") (subject to certain adjustments therein), and (iii) one Series B warrant to purchase such number of Class A Ordinary Share described in the prospectus of the Offering (the "Series B Warrant", together with the Series A Warrant, the "Warrants"). The Warrants will have a term of 5 years from the closing date of the Offering (the "Closing Date"). The Series A Warrant is exercisable immediately upon issuance, or the Closing Date. The Series B Warrant is exercisable at any time on or after the sixteenth (16th) calendar day from the Closing Date (the "Series B Exercise Date"). The Series A Warrants have an initial exercise price of $3.00 per Class A Ordinary Share. On the Series B Exercise Date, the exercise price of the Series A Warrant will be adjusted to $0.60 and the maximum number of Class A Ordinary Shares issuable upon exercise of the Series A Warrants will be adjusted to 20,000,000 shares. The exercise price of the Series B Warrants is $0.0001 per Class A Ordinary Share. The maximum number of shares issuable upon exercise of the Series B Warrants will be 16,000,000 shares. The Units have no stand-alone rights and will not be certificated or issued as stand-alone securities. The Class A Ordinary Shares, the Pre-Funded Warrants, and related Warrants are immediately separable and will be issued separately in the Offering.

Offerings

Haoxi Health Technology Limited Announces Pricing Of A $12M Underwritten Follow-On Public Offering Of 4M Units At A Price Of $3/Unit

AIM ImmunoTech shares are trading higher after the company announced preliminary data from its Phase 1b/2 study of Ampligen and Imfinzi.

Fortinet's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FTNT#NYSE">FTNT</a>) short percent of float has risen 5.34% since its last report. The company recently reported that it has 13.72 million shares sold short, which is 2.17% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.67 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Fortinet Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1726752632_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Fortinet has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Fortinet's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Fortinet's peer group average for short interest as a percentage of float is 4.64%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

YCQH Agricultural Tech

YCQH Agricultural Tech (YCQH) Forecast

YCQH Agricultural Tech (OTC:YCQH) Stock, Quote.Headers.trade-ideas